| Primary |
| Chronic Obstructive Pulmonary Disease |
23.0% |
| Hypertension |
12.8% |
| Asthma |
11.2% |
| Product Used For Unknown Indication |
8.1% |
| Rhinitis Allergic |
6.0% |
| Diabetes Mellitus |
4.4% |
| Hyperlipidaemia |
4.2% |
| Myocardial Ischaemia |
3.4% |
| Coronary Artery Disease |
2.9% |
| Chest Pain |
2.6% |
| Insomnia |
2.6% |
| Prophylaxis |
2.6% |
| Hypercholesterolaemia |
2.3% |
| Mycobacterium Avium Complex Infection |
2.3% |
| Benign Prostatic Hyperplasia |
2.1% |
| Hypothyroidism |
2.1% |
| Pain |
2.1% |
| Depression |
1.8% |
| Parkinson's Disease |
1.8% |
| Back Pain |
1.6% |
|
| Pneumonia |
17.1% |
| Chronic Obstructive Pulmonary Disease |
12.2% |
| Drug Ineffective |
8.5% |
| Mycobacterium Avium Complex Infection |
7.3% |
| Weight Decreased |
4.9% |
| Anosmia |
3.7% |
| Asthma |
3.7% |
| Chorioretinopathy |
3.7% |
| Death |
3.7% |
| Drug Eruption |
3.7% |
| Dyspnoea |
3.7% |
| Headache |
3.7% |
| Hypersensitivity |
3.7% |
| Lenticular Opacities |
3.7% |
| Somnolence |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Aneurysm |
2.4% |
| Asthenia |
2.4% |
| Atrial Flutter |
2.4% |
| Cellulitis |
2.4% |
|
| Secondary |
| Asthma |
23.3% |
| Product Used For Unknown Indication |
13.3% |
| Chronic Obstructive Pulmonary Disease |
12.7% |
| Ill-defined Disorder |
8.0% |
| Arteriosclerosis Coronary Artery |
5.3% |
| Chronic Sinusitis |
5.3% |
| Hypertension |
4.7% |
| Depression |
4.0% |
| Menopausal Symptoms |
3.3% |
| Lower Respiratory Tract Infection |
2.7% |
| Rhinitis Allergic |
2.7% |
| Bone Disorder |
2.0% |
| Diabetes Mellitus |
2.0% |
| Hyperlipidaemia |
2.0% |
| Prophylaxis |
2.0% |
| Anticoagulant Therapy |
1.3% |
| Arthralgia |
1.3% |
| Arthropathy |
1.3% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Chest Pain |
1.3% |
|
| Lactic Acidosis |
15.4% |
| Cushing's Syndrome |
7.7% |
| Suicidal Behaviour |
7.7% |
| Urinary Retention |
7.7% |
| Ageusia |
3.8% |
| Cerebellar Infarction |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Diabetes Mellitus Inadequate Control |
3.8% |
| Drug Eruption |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Ineffective |
3.8% |
| Dyspnoea |
3.8% |
| Glaucoma |
3.8% |
| Headache |
3.8% |
| Hypotension |
3.8% |
| Intracranial Pressure Increased |
3.8% |
| Mental Status Changes |
3.8% |
| Pelvic Fracture |
3.8% |
| Pharyngeal Erythema |
3.8% |
| Rib Fracture |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
50.8% |
| Asthma |
8.3% |
| Hypertension |
5.8% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Pain |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Crohn's Disease |
2.2% |
| Depression |
2.2% |
| Multiple Allergies |
2.1% |
| Hypersensitivity |
1.9% |
| Supplementation Therapy |
1.7% |
| Rhinitis Allergic |
1.6% |
| Contraception |
1.5% |
| Nasopharyngeal Cancer |
1.5% |
| Atrial Fibrillation |
1.4% |
| Premenstrual Syndrome |
1.2% |
| Vitamin Supplementation |
1.1% |
| Multiple Myeloma |
1.0% |
| Blood Cholesterol Increased |
1.0% |
|
| Bronchitis |
7.3% |
| Chronic Obstructive Pulmonary Disease |
7.3% |
| Nausea |
7.3% |
| Deep Vein Thrombosis |
6.4% |
| Vascular Pseudoaneurysm |
6.4% |
| Anxiety |
5.5% |
| Asthma |
5.5% |
| Cough |
4.6% |
| Electrocardiogram Qt Prolonged |
4.6% |
| Headache |
4.6% |
| Pneumonia |
4.6% |
| Pulmonary Embolism |
4.6% |
| Upper Respiratory Tract Infection |
4.6% |
| Vomiting |
4.6% |
| Atrial Fibrillation |
3.7% |
| Death |
3.7% |
| Drug Ineffective |
3.7% |
| Dyspnoea |
3.7% |
| Oedema |
3.7% |
| Pain |
3.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
83.3% |
| Sinus Disorder |
16.7% |
|
|
